Applications of nanotechnology to imaging and therapy of brain tumors

Neuroimaging Clinics of North America

Volumn 20, Issue 3, 2010, Pages 283-292

  Mohs, Aaron M ^a   Provenzale, James M ^a,b,c  

^a Emory University   (United States)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Brain tumor; Magnetic resonance imaging; Nanomedicine

Indexed keywords

DOXORUBICIN; GADODIAMIDE; GADOLINIUM; GOLD NANOPARTICLE; IRON OXIDE; LIPOSOME; NANOPARTICLE; QUANTUM DOT; TOPOTECAN; ULTRASMALL SUPERPARAMAGNETIC IRON OXIDE;

BLOOD BRAIN BARRIER; BRAIN TUMOR; CANCER CHEMOTHERAPY; CONTROLLED DRUG RELEASE; DISEASE MODEL; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG STABILITY; ENCAPSULATION; HUMAN; HYDROPHILICITY; HYDROPHOBICITY; KAPOSI SARCOMA; MICELLE; MULTIPLE MYELOMA; NANOTECHNOLOGY; NEUROIMAGING; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; OVARY CANCER; PRIORITY JOURNAL; RAMAN SPECTROMETRY; REVIEW; TUMOR XENOGRAFT;

ANIMALS; BLOOD-BRAIN BARRIER; BRAIN; BRAIN NEOPLASMS; DRUG DELIVERY SYSTEMS; HUMANS; MAGNETIC RESONANCE IMAGING; NANOPARTICLES; NANOTECHNOLOGY; RATS;

EID: 77955568806     PISSN: 10525149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nic.2010.04.002     Document Type: Review

References (49)

1. Ferrari M. Cancer nanotechnology: opportunities and challenges. Nat Rev Cancer 2005, 5(3):161-171.
2. Alivisatos P. The use of nanocrystals in biological detection. Nat Biotechnol 2004, 22(1):47-52.
3. Torchilin V.P. Multifunctional nanocarriers. Adv Drug Deliv Rev 2006, 58(14):1532-1555.
4. Ruiz M.A., Clares B., Morales M.E., et al. Vesicular lipidic systems, liposomes, plo, and liposomes-plo: characterization by electronic transmission microscopy. Drug Dev Ind Pharm 2008, 34(12):1269-1276.
5. Torchilin V.P. Peg-based micelles as carriers of contrast agents for different imaging modalities. Adv Drug Deliv Rev 2002, 54(2):235-252.
6. Torchilin V.P. Polymeric contrast agents for medical imaging. Curr Pharm Biotechnol 2000, 1(2):183-215.
7. James N.D., Coker R.J., Tomlinson D., et al. Liposomal doxorubicin (doxil): an effective new treatment for kaposi's sarcoma in aids. Clin Oncol (R Coll Radiol) 1994, 6(5):294-296.
8. Torchilin V.P. Recent advances with liposomes as pharmaceutical carriers. Nat Rev Drug Discov 2005, 4(2):145-160.
9. Liu L., Venkatraman S.S., Yang Y.Y., et al. Polymeric micelles anchored with tat for delivery of antibiotics across the blood-brain barrier. Biopolymers 2008, 90(5):617-623.
10. Sethuraman V.A., Lee M.C., Bae Y.H. A biodegradable ph-sensitive micelle system for targeting acidic solid tumors. Pharm Res 2008, 25(3):657-666.
11. Laurent S., Forge D., Port M., et al. Magnetic iron oxide nanoparticles: synthesis, stabilization, vectorization, physicochemical characterizations, and biological applications. Chem Rev 2008, 108(6):2064-2110.
12. Sahoo Y., Goodarzi A., Swihart M.T., et al. Aqueous ferrofluid of magnetite nanoparticles: fluorescence labeling and magnetophoretic control. J Phys Chem B 2005, 109(9):3879-3885.
13. Liu Q., Xu Z., Finch J.A., et al. A novel two-step silica-coating process for engineering magnetic nanocomposites. Chem Mater 1998, 10(12):3936-3940.
14. Sun C., Veiseh O., Gunn J., et al. In vivo MRI detection of gliomas by chlorotoxin-conjugated superparamagnetic nanoprobes. Small 2008, 4(3):372-379.
15. Neuwelt E.A., Varallyay P., Bago A.G., et al. Imaging of iron oxide nanoparticles by MR and light microscopy in patients with malignant brain tumours. Neuropathol Appl Neurobiol 2004, 30(5):456-471.
16. Wang Y.X., Hussain S.M., Krestin G.P. Superparamagnetic iron oxide contrast agents: physicochemical characteristics and applications in MR imaging. Eur Radiol 2001, 11(11):2319-2331.
17. Ghosh P., Han G., De M., et al. Gold nanoparticles in delivery applications. Adv Drug Deliv Rev 2008, 60(11):1307-1315.
18. Dixit V., Van den Bossche J., Sherman D.M., et al. Synthesis and grafting of thioctic acid-peg-folate conjugates onto au nanoparticles for selective targeting of folate receptor-positive tumor cells. Bioconjug Chem 2006, 17(3):603-609.
19. Paciotti G.F., Myer L., Weinreich D., et al. Colloidal gold: a novel nanoparticle vector for tumor directed drug delivery. Drug Deliv 2004, 11(3):169-183.
20. Daniel M.C., Astruc D. Gold nanoparticles: assembly, supramolecular chemistry, quantum-size-related properties, and applications toward biology, catalysis, and nanotechnology. Chem Rev 2004, 104(1):293-346.
21. Elghanian R., Storhoff J.J., Mucic R.C., et al. Selective colorimetric detection of polynucleotides based on the distance-dependent optical properties of gold nanoparticles. Science 1997, 277(5329):1078-1081.
22. Nie S., Emory S.R. Probing single molecules and single nanoparticles by surface-enhanced raman scattering. Science 1997, 275(5303):1102-1106.
23. Cao Y.C., Jin R., Mirkin C.A. Nanoparticles with raman spectroscopic fingerprints for DNA and RNA detection. Science 2002, 297(5586):1536-1540.
24. Qian X., Peng X.H., Ansari D.O., et al. In vivo tumor targeting and spectroscopic detection with surface-enhanced raman nanoparticle tags. Nat Biotechnol 2008, 26(1):83-90.
25. Huang X., El-Sayed I.H., Qian W., et al. Cancer cell imaging and photothermal therapy in the near-infrared region by using gold nanorods. J Am Chem Soc 2006, 128(6):2115-2120.
26. Bruchez M., Moronne M., Gin P., et al. Semiconductor nanocrystals as fluorescent biological labels. Science 1998, 281(5385):2013-2016.
27. Smith A.M., Duan H., Mohs A.M., et al. Bioconjugated quantum dots for in vivo molecular and cellular imaging. Adv Drug Deliv Rev 2008, 60(11):1226-1240.
28. Murray C.B., Norris D.J., Bawendi M.G. Synthesis and characterization of nearly monodisperse cde (e = sulfur, selenium, tellurium) semiconductor nanocrystallites. J Am Chem Soc 1993, 115(19):8706-8715.
29. Dabbousi B.O., Rodriguez-Viejo J., Mikulec F.V., et al. (CdSe)ZnS core-shell quantum dots: synthesis and characterization of a size series of highly luminescent nanocrystallites. J Phys Chem B 1997, 101(46):9463-9475.
30. Smith A.M., Duan H., Rhyner M.N., et al. A systematic examination of surface coatings on the optical and chemical properties of semiconductor quantum dots. Phys Chem Chem Phys 2006, 8:3895-3903.
31. Dubertret B., Skourides P., Norris D.J., et al. In vivo imaging of quantum dots encapsulated in phospholipid micelles. Science 2002, 298(5599):1759-1762.
32. Gao X., Cui Y., Levenson R.M., et al. In vivo cancer targeting and imaging with semiconductor quantum dots. Nat Biotechnol 2004, 22(8):969-976.
33. Xing Y., Chaudry Q., Shen C., et al. Bioconjugated quantum dots for multiplexed and quantitative immunohistochemistry. Nat Protoc 2007, 2(5):1152-1165.
34. Wu X., Liu H., Liu J., et al. Immunofluorescent labeling of cancer marker her2 and other cellular targets with semiconductor quantum dots. Nat Biotechnol 2003, 21(1):41-46.
35. Choi H.S., Liu W., Misra P., et al. Renal clearance of quantum dots. Nat Biotechnol 2007, 25(10):1165-1170.
36. Smith A.M., Nie S. Minimizing the hydrodynamic size of quantum dots with multifunctional multidentate polymer ligands. J Am Chem Soc 2008, 130(34):11278-11279.
37. Pradhan N., Battaglia D.M., Liu Y., et al. Efficient, stable, small, and water-soluble doped znse nanocrystal emitters as noncadmium biomedical labels. Nano Lett 2007, 7(2):312-317.
38. Smith A.M., Mohs A.M., Nie S. Tuning the optical and electronic properties of colloidal nanocrystals by lattice strain. Nat Nanotechnol 2009, 4(1):56-63.
39. Orringer D.A., Koo Y.E., Chen T., et al. Small solutions for big problems: the application of nanoparticles to brain tumor diagnosis and therapy. Clin Pharmacol Ther 2009, 85(5):531-534.
40. Gelperina S., Kisich K., Iseman M.D., et al. The potential advantages of nanoparticle drug delivery systems in chemotherapy of tuberculosis. Am J Respir Crit Care Med 2005, 172(12):1487-1490.
41. Bart J., Groen H.J., Hendrikse N.H., et al. The blood-brain barrier and oncology: new insights into function and modulation. Cancer Treat Rev 2000, 26(6):449-462.
42. Chavanpatil M.D., Khdair A., Gerard B., et al. Surfactant-polymer nanoparticles overcome p-glycoprotein-mediated drug efflux. Mol Pharm 2007, 4(5):730-738.
43. Brioschi A., Zenga F., Zara G.P., et al. Solid lipid nanoparticles: could they help to improve the efficacy of pharmacologic treatments for brain tumors?. Neurol Res 2007, 29(3):324-330.
44. Sampson J.H., Raghavan R., Provenzale J.M., et al. Induction of hyperintense signal on T2-weighted MR images correlates with infusion distribution from intracerebral convection-enhanced delivery of a tumor-targeted cytotoxin. AJR Am J Roentgenol 2007, 188(3):703-709.
45. Moog R., Burger A.M., Brandl M., et al. Change in pharmacokinetic and pharmacodynamic behavior of gemcitabine in human tumor xenografts upon entrapment in vesicular phospholipid gels. Cancer Chemother Pharmacol 2002, 49(5):356-366.
46. Saito R., Krauze M.T., Noble C.O., et al. Convection-enhanced delivery of ls-tpt enables an effective, continuous, low-dose chemotherapy against malignant glioma xenograft model. Neuro Oncol 2006, 8(3):205-214.
47. Perlstein B., Ram Z., Daniels D., et al. Convection-enhanced delivery of maghemite nanoparticles: Increased efficacy and MRI monitoring. Neuro Oncol 2008, 10(2):153-161.
48. Grahn A.Y., Bankiewicz K.S., Dugich-Djordjevic M., et al. Non-pegylated liposomes for convection-enhanced delivery of topotecan and gadodiamide in malignant glioma: initial experience. J Neurooncol 2009, 95(2):185-197.
49. Peng X.H., Qian X., Mao H., et al. Targeted magnetic iron oxide nanoparticles for tumor imaging and therapy. Int J Nanomedicine 2008, 3(3):311-321.